The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

Condition:   SARS-CoV-2 Infection Interventions:   Drug: Azvudine;   Drug: Paxlovid group Sponsors:   Southeast University, China;   Hohhot First Hospital, Hohhot, Inner Mongolia, China Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials